MNTA: After perusing various docs, one gets the distinct impression that: 1. Sandoz/MNTA know more about a given batch of Copaxone than Teva or 2. Teva is being borderline deceitful or both.
In any event, I still believe this remains bullish for MNTA and still believe the perceived delay increases the likelihood of a SJ against Teva.